Longitudinal studies have also demonstrated a rapid activation of SARS-CoV-2-specific cellular immune responses during breakthrough infections, explained both by the recall of CD4+ and CD8+ spike-specific memory cells and de novo T cell responses [44]. This evidence concerns the gene CD8A and infection.